Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

3 Pot Stocks That Could Make Investors Filthy Rich

By Eric Volkman - Dec 14, 2020 at 9:19AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This trio were among the trailblazers in the key states that just legalized marijuana.

Of the five states that flipped the switch on marijuana legalization on Election Day, three are populous and full of pot consumers. Therefore, they are extremely fertile ground for the few publicly traded companies that were forward-thinking enough to put down roots there.

Healthcare and cannabis bureau chief Corinne Cardina Jurney and Motley Fool contributor Eric Volkman take a brief look at three stocks poised to turn their early efforts into meaningful businesses in those locations, in this segment from Motley Fool Live recorded on Nov. 18.

 

Corinne Cardina: Let's touch on a couple of stocks. Let's give the people what they want. What multi-state operators are poised to benefit from these new markets as they open up?

Eric Volkman: Okay. Well, one you had pointed out to me, which I think is pretty interesting one is a little bit smaller, it's Harvest Health and Recreation ( HRVSF ).

Harvest Health has the great advantage of being based in Arizona, that's their home. They already operate 15 dispensaries there, scattered throughout the state, but Arizona is basically... the big population center there is Phoenix, which I think is something like 20% of the entire population of the state. Harvest Health's dispensaries tend to be clustered around there, but they have them in different parts of the state. So assuming that, again, that transition from medical only to medical and recreational, dispensary operating is not that awful and not that painful, these guys, I think are going to get an immediate boost particularly to their revenue. It's exciting and there's an awful lot of possibilities.

But investors do need to track what the progress is with the state ramping up to recreational sales too.

Corinne Cardina: Awesome. Anything in New Jersey?

Eric Volkman: New Jersey is a Johnny-come-lately. I don't know exactly when -- you might have this information on you -- but I don't know exactly when they legalized medical weed. It wasn't that long ago. They were not that generous with the licenses, so there's only really a clutch of dispensaries in the entire state.

We've got Curaleaf ( CURLF -1.74% ), I think has two dispensaries. Green Thumb Industries ( GTBIF 0.64% ), I believe has one or two under their Rise brand. It's much different animal than Arizona. You really don't have a lot of boots on the ground there, you don't have a lot of facilities. That's going to take a little bit more time, but I think there's still enormous potential there.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Harvest Health & Recreation Inc. Stock Quote
Harvest Health & Recreation Inc.
HRVSF
Green Thumb Industries Stock Quote
Green Thumb Industries
GTBIF
$21.66 (0.64%) $0.14
Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$9.28 (-1.74%) $0.16

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
652%
 
S&P 500 Returns
145%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/09/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.